Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85629496 | 8562949 | 6 | F | 20120316 | 20160823 | 20120515 | 20160929 | EXP | US-ROCHE-1067335 | ROCHE | 67.00 | YR | M | Y | 49.70000 | KG | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85629496 | 8562949 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG IV OVER 30-90 MIN | D | 125085 | 10 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 85629496 | 8562949 | 2 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | D | 0 | 25 | MG | ||||||||
| 85629496 | 8562949 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 4 | C | SODIUM PHOSPHATE | SODIUM PHOSPHATE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 7 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 9 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 10 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 11 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 85629496 | 8562949 | 12 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 85629496 | 8562949 | 1 | Malignant neoplasm of islets of Langerhans |
| 85629496 | 8562949 | 2 | Malignant neoplasm of islets of Langerhans |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 85629496 | 8562949 | DE |
| 85629496 | 8562949 | OT |
| 85629496 | 8562949 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 85629496 | 8562949 | Cardiac arrest | |
| 85629496 | 8562949 | Dehydration | |
| 85629496 | 8562949 | Fatigue | |
| 85629496 | 8562949 | Hypokalaemia | |
| 85629496 | 8562949 | Hypophosphataemia | |
| 85629496 | 8562949 | Oesophageal pain | |
| 85629496 | 8562949 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 85629496 | 8562949 | 1 | 20111216 | 20120309 | 0 | |
| 85629496 | 8562949 | 2 | 20111216 | 20120330 | 0 |